Mayo Clinic Reports Tamoxifen Benefit For Breast-cancer Patients Tied To Inherited Gene
19th Dec 2005, 16:14 GMT
One of the most commonly administered drugs for breast cancer, tamoxifen, may not be as effective for women who inherit a common genetic change, according to researchers at Mayo Clinic and the University of Michigan.
Mayo Clinic Reports Tamoxifen Benefit For Breast-cancer Patients Tied To Inherited Gene related news:
- Gene Variation Affects Tamoxifen's Benefit For Breast Cancer — ScienceDaily Headlines: Health & Medicine
- Mayo Clinic finds kidney cancer patients are unlikely to respond to potential treatment drug — EurekAlert! - Cancer
- Aromatase inhibitor shows promise for breast cancer patients — The Cancer Blog
- Common gene variation lessens Tamoxifen’s benefit — News-Medical News Feed
- Genes May Determine Cancer Drug's Effectiveness — TechNewsWorld
- Gene May Undermine Tamoxifen's Effectiveness (HealthDay) — Yahoo! News: Health News
- Univ. of Chicago researchers license pharmacogenomics test for patients with colorectal cancer to Mayo — EurekAlert! - Cancer
- Mayo Clinic Discovers Two Key Players In Cancer Prevention And How They Work — ScienceDaily Headlines: Health & Medicine
- U Chicago researchers license pharmacogenomics test for patients with colorectal cancer to Mayo — EurekAlert! - Biology
- Imatinib mesylate (Gleevec) may not be effective at treating kidney cancer — News-Medical News Feed
Latest news from ScienceDaily Headlines:
- Move Over, Penicillin: Researchers Mold Clay Into Potential Therapy
- Researchers Turn Cord Blood Into Lung Cells
- Keeping E. Coli Out Of Meat
- MRI Analysis Could Prevent Brain Damage From Stroke, Study Finds
- Shift Toward Services Industries Won't End Global Warming
- More Species In The Tropics Because Species Have Been There Longer, Study Suggests
- Grace Under Pressure: Researchers Analyze Effects Of Stress On Decision-making Ability
- 'Alzheimer's Gene' Protects Children From Severe Diarrhea
- European Airborne Campaign Simulates Sentinel Imagery Over Land
- Newly Identified Biomarker Detects And Regulates Spread Of Brain Tumors